1. BUSINESS AIMS
A company developed a new product for gastroesophageal reflux disease and launched a phase III clinical trial. In addition to the product, the company created a draft value proposition based on secondary and primary research and decided to test it as aspirational messages on the Russian market.
2. BAZIS HEALTH SOLUTION
We used web assisted, in-depth interviews with gastroenterologists to test a draft value proposition and get a deeper understanding of GERD treatment in Russia for further product promotion.
3. CLIENT IMPACT
Thanks to our findings, the client was able to develop a final value proposition for the Russian market. The project results proved that more detailed information about medication efficiency is needed to increase the number of prescriptions.